Earnings Per Share, Basic of Nabriva Therapeutics plc from 31 Dec 2014 to 30 Jun 2023

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: Nabriva Therapeutics plc quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Dec 2014 to 30 Jun 2023.
Nabriva Therapeutics plc Earnings Per Share, Basic for the quarter ending 30 Jun 2023 was -3.73, a 15% increase year-over-year.
Nabriva Therapeutics plc Earnings Per Share, Basic for the twelve months ending 30 Jun 2023 was -18, a 51% increase year-over-year.
Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2022 was -21.32, a 25% increase from 2021.
Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2021 was -28.52, a 79% increase from 2020.
Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2020 was -135, a 1113% decline from 2019.
Source SEC data: View on sec.gov

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Quarterly (USD/shares)

Earnings Per Share, Basic, YoY Quarterly Change (%)

Earnings Per Share, Basic, Annual (USD/shares)

Earnings Per Share, Basic, YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Earnings Per Share, Basic (USD/shares)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2023	-18	-3.73	+0.65	+15%	01 Apr 2023	30 Jun 2023	10-Q	19 Oct 2023	2023	Q2
Q1 2023	-19	-2.72	+2.31	+46%	01 Jan 2023	31 Mar 2023	10-Q	22 May 2023	2023	Q1
Q4 2022	-21	-7.7	+14.73	+66%	01 Oct 2022	31 Dec 2022	10-K	17 Apr 2023	2022	FY
Q3 2022	-36	-4.21	+1.06	+20%	01 Jul 2022	30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	-37	-4.38	-4.09	-1410%	01 Apr 2022	30 Jun 2022	10-Q	19 Oct 2023	2023	Q2
Q1 2022	-33	-5.03	-4.5	-849%	01 Jan 2022	31 Mar 2022	10-Q	22 May 2023	2023	Q1
Q4 2021	-29	-22.43			01 Oct 2021	31 Dec 2021	10-K	17 Apr 2023	2022	FY
Q3 2021		-5.27	-4.37	-486%	01 Jul 2021	30 Sep 2021	10-Q	10 Nov 2022	2022	Q3
Q2 2021		-0.29	+1.08	+79%	01 Apr 2021	30 Jun 2021	10-Q	03 Aug 2022	2022	Q2
Q1 2021		-0.53			01 Jan 2021	31 Mar 2021	10-Q	05 May 2022	2022	Q1
Q3 2020		-0.9			01 Jul 2020	30 Sep 2020	10-Q	09 Nov 2021	2021	Q3
Q2 2020		-1.37			01 Apr 2020	30 Jun 2020	10-Q	05 Aug 2021	2021	Q2
Q2 2017	-20	-0.54	+0.03	+5.3%	01 Apr 2017	30 Jun 2017	10-Q	07 Aug 2017	2017	Q2
Q1 2017	-20	-5.6	+0.82	+13%	01 Jan 2017	31 Mar 2017	10-Q	10 May 2017	2017	Q1
Q4 2016	-20	-6.84	-3.05	-80%	01 Oct 2016	31 Dec 2016	10-K	24 Mar 2017	2016	FY
Q3 2016	-17	-6.58	+0.88	+12%	01 Jul 2016	30 Sep 2016	10-K	24 Mar 2017	2016	FY
Q2 2016	-18	-0.57	+36.97	+98%	01 Apr 2016	30 Jun 2016	10-Q	07 Aug 2017	2017	Q2
Q1 2016	-55	-6.42	+24.18	+79%	01 Jan 2016	31 Mar 2016	10-Q	10 May 2017	2017	Q1
Q4 2015	-79	-3.79			01 Oct 2015	31 Dec 2015	10-K	24 Mar 2017	2016	FY
Q3 2015		-7.46			01 Jul 2015	30 Sep 2015	10-K	24 Mar 2017	2016	FY
Q2 2015		-37.54			01 Apr 2015	30 Jun 2015	10-K	24 Mar 2017	2016	FY
Q1 2015		-30.6			01 Jan 2015	31 Mar 2015	10-K	24 Mar 2017	2016	FY

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2022	-21.32	+7.2	+25%	01 Jan 2022	31 Dec 2022	10-K	17 Apr 2023	2022	FY
2021	-28.52	+107	+79%	01 Jan 2021	31 Dec 2021	10-K	17 Apr 2023	2022	FY
2020	-135	-124	-1113%	01 Jan 2020	31 Dec 2020	10-K	17 Apr 2023	2022	FY
2019	-11.15			01 Jan 2019	31 Dec 2019	10-K	29 Mar 2022	2021	FY
2016	-25.56	+22.47	+47%	01 Jan 2016	31 Dec 2016	10-K	24 Mar 2017	2016	FY
2015	-48.03	-3.64	-8.2%	01 Jan 2015	31 Dec 2015	10-K	24 Mar 2017	2016	FY
2014	-44.39			01 Jan 2014	31 Dec 2014	10-K	24 Mar 2017	2016	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.